Table 3.

Clinical Features of Patients with Splenic Infarction at Diagnosis (n=15).

Age (yr), median (range)		58 (22-88)
Male, n (%)		10 (66.7)
Symptoms relevant to splenic infarction, n (%)
Abdominal pain		8 (53.3)
Vague abdominal discomfort		2 (13.3)
None		5 (33.3)
Splenomegaly
Palpable splenomegaly, n (%)		8 (53.3)
Volumetric splenomegaly, n (%)		7 (46.7)
No splenomegaly, n (%)		0 (0.0)
Extent of splenic infarction, n (%)
Solitary		5 (33.3)
Multifocal		9 (60.0)
Extensive		1 (6.7)
Laboratory findings
WBC, ×109/L		17.1±12.1
Monocyte, ×109/L		1.1±0.8
Hemoglobin, g/dL		15.2±5.1
Platelet, ×109/L		517.6±447.3
LDH, ×UNL		2.3±1.7
Diver gene mutation
JAK2V617F		11/14 (78.6)
CALR		2/14 (14.3)
Comorbidity
Hypertension		4 (26.7)
Diabetes mellitus		3 (20.0)
Chronic kidney disease		2 (13.3)
Smoking		6 (40.0)
Thrombotic events, n (%)*		5 (33.3)
Hemorrhagic event, n (%)*		1 (6.7)
Follow-up duration (yr), median (range)		4.3 (0.6-20.5)

*Events before, at the time of, and after MPN diagnosis.